The Alzheimer's problem

• Autores: Andy Coghlan
• Localización: New scientist, ISSN 0262-4079, Nº. 3110, 2017, págs. 22-23
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Coghlan discusses a game-changing drug for Alzheimer's disease. Almost all clinical trials of new drugs to combat Alzheimer's fail. No drug has bucked the trend in 20 years, but people wouldn't know it from the constant promises of a breakthrough. Last November, after the failure of a particularly high-profile trial, for some the jig was up. Alzheimer's is the most common cause of dementia, and by some metrics its prevalence is rising. Alzheimer's Disease International estimates that, in 2015, 46.8 million people worldwide had dementia, a number that is set to double every 20 years, mostly because of an increasing number of older people in developing countries like India and China, leading to a global healthcare crisis.